{
    "clinical_study": {
        "@rank": "82330", 
        "arm_group": [
            {
                "arm_group_label": "STW5", 
                "arm_group_type": "Experimental", 
                "description": "Application over 28 days 20 drops three times daily"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Application over 28 days 20 drops three times daily"
            }
        ], 
        "brief_summary": {
            "textblock": "The study shall prove whether treatment of irritable bowel syndrome with Iberogast is\n      superior to placebo."
        }, 
        "brief_title": "Efficacy/Safety Study to Confirm Iberogast's Efficacy in Rome-III Patients in Irritable Bowel Syndrome", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Irritable Bowel Syndrome", 
        "condition_browse": {
            "mesh_term": "Irritable Bowel Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients of either sex aged >18 years\n\n          -  Patients meeting the Rome III irritable bowel syndrome (IBS) diagnostic criteria. IBS\n             is defined as recurrent abdominal pain or discomfort at least 3 days/month in last 3\n             months (onset at least 6 months ago) associated with two or more of the following:\n\n               -  Improvement with defecation\n\n               -  Onset associated with a change in frequency of stool\n\n               -  Onset associated with a change in form (appearance) of stool\n\n          -  History of pain intensity with an average of worst abdominal pain in past 24 hours\n             score of > 30 on a daily measured VAS (visual analogue scale) during screening phase\n\n        Exclusion Criteria:\n\n          -  Intake of STW5 within the last 5 years\n\n          -  Concomitant treatment during the study (including screening phase) with any\n             medication that could influence the gastrointestinal function\n\n          -  Regular intake of nonsteroidal antiphlogistic drugs incl. COX-2-inhibitors\n             (exception: acetylsalicylic acid for cardiovascular prevention up to 100 mg daily)\n\n          -  Patients with known hypersensitivity to any component of the trial drugs\n\n          -  History of eating disorders\n\n          -  Patients with a history of diseases with abdominal symptoms that can resemble IBS\n\n          -  Presence of any other acute or chronic gastrointestinal disorder\n\n          -  History of abdominal surgery (cholecystectomy and appendectomy can be tolerated when\n             performed at least one year previously)\n\n          -  Known intolerance to azo dyes E 110 and E 151"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "237", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01940848", 
            "org_study_id": "17063", 
            "secondary_id": [
                "2011-002613-10", 
                "STW5/212-D-011-III-V"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "STW5", 
                "intervention_name": "STW5 (Iberogast, BAY98-7411)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Iberogast", 
            "efficacy", 
            "safety"
        ], 
        "lastchanged_date": "May 16, 2014", 
        "link": [
            {
                "description": "Click here and search for drug information provided by the FDA.", 
                "url": "http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm"
            }, 
            {
                "description": "Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.", 
                "url": "http://www.fda.gov/medwatch/safety.htm"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Mannheim", 
                        "country": "Germany", 
                        "state": "Baden-W\u00fcrttemberg", 
                        "zip": "68165"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Schwetzingen", 
                        "country": "Germany", 
                        "state": "Baden-W\u00fcrttemberg", 
                        "zip": "68723"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Potsdam", 
                        "country": "Germany", 
                        "state": "Brandenburg", 
                        "zip": "14482"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lollar", 
                        "country": "Germany", 
                        "state": "Hessen", 
                        "zip": "35457"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wiesbaden", 
                        "country": "Germany", 
                        "state": "Hessen", 
                        "zip": "65185"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wardenburg", 
                        "country": "Germany", 
                        "state": "Niedersachsen", 
                        "zip": "26203"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winsen", 
                        "country": "Germany", 
                        "state": "Niedersachsen", 
                        "zip": "21423"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Essen", 
                        "country": "Germany", 
                        "state": "Nordrhein-Westfalen", 
                        "zip": "45355"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hagen", 
                        "country": "Germany", 
                        "state": "Nordrhein-Westfalen", 
                        "zip": "58095"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leverkusen", 
                        "country": "Germany", 
                        "state": "Nordrhein-Westfalen", 
                        "zip": "51375"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marl", 
                        "country": "Germany", 
                        "state": "Nordrhein-Westfalen", 
                        "zip": "45770"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Recklinghausen", 
                        "country": "Germany", 
                        "state": "Nordrhein-Westfalen", 
                        "zip": "45659"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ludwigshafen", 
                        "country": "Germany", 
                        "state": "Rheinland-Pfalz", 
                        "zip": "67067"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Halle", 
                        "country": "Germany", 
                        "state": "Sachsen-Anhalt", 
                        "zip": "06108"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "12157"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13086"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13055"
                    }
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Double-blind, Randomised, Placebo-controlled Study on the Efficacy of Iberogast\u00ae (STW5) in Patients With Irritable Bowel Syndrome", 
        "overall_contact": {
            "email": "clinical-trials-contact@bayerhealthcare.com", 
            "last_name": "Bayer Clinical Trials Contact"
        }, 
        "overall_official": {
            "affiliation": "Bayer", 
            "last_name": "Bayer Study Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of responders with decrease in pain intensity compared with baseline for at least 14 single days within 4 weeks of treatment", 
            "safety_issue": "No", 
            "time_frame": "Up to 4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01940848"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of responders with decrease in pain intensity compared with baseline for at least 7 single days within first 2 weeks of treatment", 
                "safety_issue": "No", 
                "time_frame": "Up to 2 weeks"
            }, 
            {
                "measure": "Score on IBS-QOL (Irritable Bowel Syndrome - Quality of Life Measure) scale", 
                "safety_issue": "No", 
                "time_frame": "Up to 4 weeks"
            }
        ], 
        "source": "Bayer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bayer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}